Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Satomi

Showing results (11-20 of 45) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|June 1, 1985
Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophagesN Satomi, A Sakurai, K Haranaka
Journal of Biological Response Modifiers|August 1, 1987
Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapyK Haranaka, A Sakurai, N Satomi
Journal of Biological Response Modifiers|February 1, 1988
Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factorN Satomi, A Sakurai, R Haranaka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1982
[Studies on tumor necrosis factor (TNF)]K Haranaka, N Satomi, A Sakurai, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1984
Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharideK Haranaka, N Satomi, A Sakurai, et al.
International Journal of Cancer|September 15, 1985
Purification and partial amino acid sequence of rabbit tumor necrosis factorK Haranaka, N Satomi, A Sakurai, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1985
[Phagocytosis and intracellular killing of Pseudomonas aeruginosa by activated macrophages--in comparison with Staphylococcus aureus and latex particles]A Sakurai, N Satomi, K Haranaka, et al.
Journal of Biological Response Modifiers|October 1, 1989
Therapy combining tumor necrosis factor with tumor-specific antibody against Meth A sarcomaN Satomi, A Sakurai, R Haranaka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1979
[The changes of the OEP-HA titer in the sera of mice challenged with Pseudomonas aeruginosa and in the phagocytic system of macrophages in vitro (author's transl)]N Satomi, K Haranaka, O Kunii, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Role of first stimulating agents in the production of tumor necrosis factorK Haranaka, N Satomi, A Sakurai, et al.
Pageof 5

Showing results (11-20 of 45) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|June 1, 1985
Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: role of glucose, insulin, and macrophagesN Satomi, A Sakurai, K Haranaka
Journal of Biological Response Modifiers|August 1, 1987
Antitumor activity of recombinant human tumor necrosis factor in combination with hyperthermia, chemotherapy, or immunotherapyK Haranaka, A Sakurai, N Satomi
Journal of Biological Response Modifiers|February 1, 1988
Preventive effects of several chemicals against lethality of recombinant human tumor necrosis factorN Satomi, A Sakurai, R Haranaka, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 1, 1982
[Studies on tumor necrosis factor (TNF)]K Haranaka, N Satomi, A Sakurai, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1984
Role of lipid A in the production of tumor necrosis factor and differences in antitumor activity between tumor necrosis factor and lipopolysaccharideK Haranaka, N Satomi, A Sakurai, et al.
International Journal of Cancer|September 15, 1985
Purification and partial amino acid sequence of rabbit tumor necrosis factorK Haranaka, N Satomi, A Sakurai, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|June 1, 1985
[Phagocytosis and intracellular killing of Pseudomonas aeruginosa by activated macrophages--in comparison with Staphylococcus aureus and latex particles]A Sakurai, N Satomi, K Haranaka, et al.
Journal of Biological Response Modifiers|October 1, 1989
Therapy combining tumor necrosis factor with tumor-specific antibody against Meth A sarcomaN Satomi, A Sakurai, R Haranaka, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|August 1, 1979
[The changes of the OEP-HA titer in the sera of mice challenged with Pseudomonas aeruginosa and in the phagocytic system of macrophages in vitro (author's transl)]N Satomi, K Haranaka, O Kunii, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1984
Role of first stimulating agents in the production of tumor necrosis factorK Haranaka, N Satomi, A Sakurai, et al.
Pageof 5